Core Insights - Spring Medical (688236.SH) reported a total revenue of 756 million yuan for Q3 2025, with a net profit attributable to shareholders of 192 million yuan and a net cash inflow from operating activities of 175 million yuan [1]. Financial Performance - The company's latest debt-to-asset ratio stands at 15.65% [3]. - The gross profit margin is 67.27%, which is a decrease of 2.03 percentage points compared to the same period last year [3]. - The return on equity (ROE) is reported at 6.42% [3]. - The diluted earnings per share (EPS) is 0.50 yuan [3]. - The total asset turnover ratio is 0.22 times, ranking 79th among disclosed peers [3]. - The inventory turnover ratio is 0.44 times, ranking 127th among disclosed peers [3]. Shareholder Structure - The number of shareholders is 6,164, with the top ten shareholders holding a total of 249 million shares, accounting for 64.88% of the total share capital [3]. - The top ten shareholders and their respective holdings are as follows: - Shi Chunbao: 31.3 million shares - Yue Mujun: 24.8 million shares - Beijing Panmao Investment Management Co., Ltd.: 4.50 million shares - Hong Kong Central Clearing Limited: 0.77 million shares - Huaxia Bank Co., Ltd.: 0.74 million shares - Huang Dong: 0.66 million shares - Beijing Panmao Investment Management Co., Ltd.: 0.65 million shares - Agricultural Bank of China: 0.55 million shares - Huatai Securities Asset Management: 0.43 million shares - Beijing Chunli Zhengda Medical Device Co., Ltd.: 0.36 million shares [3].

Core Insights - The company reported a total revenue of 1.068 billion yuan for the first half of 2025, with a net profit attributable to shareholders of -52.36 million yuan, indicating a loss [1] - The operating cash flow showed a net outflow of 132 million yuan, reflecting challenges in cash generation [1] Financial Performance - The latest debt-to-asset ratio stands at 43.55%, which is an increase of 1.58 percentage points from the previous quarter and an increase of 14.35 percentage points year-on-year [3] - The gross profit margin is reported at 9.16%, down by 2.42 percentage points compared to the previous quarter [3] - The return on equity (ROE) is -1.67%, indicating negative returns for shareholders [3] - The diluted earnings per share (EPS) is -0.10 yuan, reflecting the company's loss [3] Operational Efficiency - The total asset turnover ratio is 0.17 times, suggesting low efficiency in utilizing assets to generate revenue [3] - The inventory turnover ratio is 2.28 times, which is a decrease of 0.25 times year-on-year, representing a decline of 9.91% [3] Shareholder Structure - The number of shareholders is reported at 80,700, with the top ten shareholders holding a total of 180 million shares, accounting for 35.86% of the total share capital [3] - The largest shareholder is Shantou Tianji Co., Ltd., holding 15.1% of the shares [3]

Financial Performance - The company's total revenue is 8.497 billion yuan, with a net profit attributable to shareholders of 1.293 billion yuan [1] - The net cash inflow from operating activities is -0.713 billion yuan, a decrease of 0.820 billion yuan compared to the same period last year, representing a year-on-year decline of 769.72% [1] - The diluted earnings per share is 1.66 yuan [4] Financial Ratios - The latest debt-to-asset ratio is 46.13%, an increase of 1.75 percentage points from the previous quarter and an increase of 3.55 percentage points from the same period last year [3] - The latest gross profit margin is 31.74%, a decrease of 0.01 percentage points compared to the same period last year [3] - The latest return on equity (ROE) is 9.66% [3] Asset Management - The latest total asset turnover ratio is 0.35 times, and the inventory turnover ratio is 1.42 times [5] Shareholder Structure - The number of shareholders is 20,000, with the top ten shareholders holding 464 million shares, accounting for 59.58% of the total share capital [5] - The largest shareholder is Hong Kong Central Clearing Limited, holding 19.90% of the shares [5]